Honeybee vaccine
Commercial- Indications
- American Foulbrood disease in honeybees
Company intelligence / Profile preview
Dalan Animal Health has developed and commercialized the world’s first approved oral vaccine to protect honeybee colonies against American Foulbrood. The company’s technology leverages maternal immune priming by feeding queen bees an oral bacterin, which then confers immunity to their offspring. Clinical studies have demonstrated safety and efficacy, with regulatory approvals including a conditional USDA license and Canadian market authorization. Early field data also suggest reduced viral loads of DWV-B following vaccination[2][5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalan Animal Health.